Ottawa, March 22, 2017– Innovative Medicines Canada President Pamela Fralick issued the following statement in response to the tabling of the federal budget: “Innovative Medicines Canada is pleased to see […]
The Future of Innovation in Canada’s Healthcare System.
Canada’s innovative pharmaceutical companies invest more than $1-billion every year in research and development to create new innovative medicines and vaccines that save or improve the lives of Canadian patients.
Canada’s health ministers are currently undergoing a vigorous policy debate on how best to sustain our health-care system…
In response to CBC’s the fifth estate, Innovative Medicines Canada issued the following statement: